Latest KFF Health News Stories
What the Health? From KFF Health News: The GOP Still Can’t Agree on a Health Plan
Senate Democrats were promised a vote by mid-December on extending enhanced Affordable Care Act subsidies, but Republicans still can’t decide whether they want to put forward their own alternative or what that might include. Meanwhile, the CDC and FDA are roiled by debates over vaccines. Alice Miranda Ollstein of Politico, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Paige Winfield Cunningham of The Washington Post join KFF Health News’ Julie Rovner to discuss those stories and more. Also, Rovner interviews KFF Health News’ Aneri Pattani about her project tracking opioid settlement payments.
Under Kennedy, America’s Health Department Is in the Business of Promoting Kennedy
Under Secretary Robert F. Kennedy Jr., the Department of Health and Human Services increasingly uses its social media channels to promote Kennedy himself and his agenda. Interviews with over 20 former and current employees provide a look inside an agency where personality and politics steer communications with the public.
What the Health? From KFF Health News: Trump Almost Unveils a Health Plan
Just weeks before some tax credits for Affordable Care Act premiums expire, the Trump administration floated a plan to extend the enhanced aid — but it was met with immediate GOP pushback. Meanwhile, health secretary Robert F. Kennedy Jr. says he ordered the Centers for Disease Control and Prevention to revise its website to suggest childhood vaccines might be linked to autism. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews Joanne Kenen and Joshua Sharfstein about their new book, “Information Sick: How Journalism’s Decline and Misinformation’s Rise Are Harming Our Health — And What We Can Do About It.”
The Covid Contrarian Clubhouse Makes Its Mark on Trump’s Washington
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
Drug industry officials and analysts praised the FDA’s plans to streamline regulation of “biosimilars,” which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S. market are getting harder to fight.
What the Health? From KFF Health News: The Government Is Open
The record-long federal shutdown is over after a small group of Democrats agreed to a deal with most Republicans that funds the government through January — but, notably, does not extend more generous Affordable Care Act tax credits. Plus, new details are emerging about how the Trump administration is using the Medicaid program to advance its policy goals. Anna Edney of Bloomberg News, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Emmarie Huetteman to discuss these stories and more. Also this week, KFF Health News’ Julie Rovner interviews KFF Health News’ Julie Appleby, who wrote the latest “Bill of the Month” feature.
Readers Take Congress to Task and Offer Their Own Health Policy Fixes
KFF Health News gives readers a chance to comment on a recent batch of stories.
Para quienes tienen en su agenda de otoño vacunarse contra enfermedades respiratorias —covid, gripe y, para algunas personas, virus respiratorio sincitial (VRS) — este año puede resultar sorprendentemente normal.
Despite the Hoopla, Vaccines Should Be in Reach This Cough-and-Cold Season
Recommendations surrounding covid vaccinations and other such shots have been confusing. Ultimately, though, little has changed. Here’s what you need to know.
What the Health? From KFF Health News: Starting To Feel the Shutdown’s Bite
The government shutdown continues with no end in sight, and while it theoretically should not affect entitlement programs, the lapse of some related authorizations — like for Medicare telehealth programs — is leaving some doctors and patients high and dry. Meanwhile, the FDA quietly approved a new generic abortion pill. Sarah Karlin-Smith of Pink Sheet, Tami Luhby of CNN, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more. Also, Rovner interviews Sarah Grusin of the National Health Law Program.
‘Historic’ White House Announcement on Autism and Tylenol Causes Confusion
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Off-Label Drug Helps One Boy With Autism Speak, Parents Say. But Experts Want More Data.
This week, the FDA began the process of approving leucovorin, an inexpensive, generic drug derived from folic acid, to help children diagnosed with autism.
Trump Claims ‘No Downside’ to Avoiding Tylenol During Pregnancy. He’s Wrong.
Doctors say acetaminophen, the main ingredient in Tylenol, is safe to take during pregnancy. Other over-the-counter pain relievers such as aspirin and ibuprofen aren’t recommended because they can harm fetal development. Untreated fever in pregnancy can pose maternal and fetal health risks.
Journalists Follow the Fallout of CDC Director’s Firing and Trump’s Health Policies
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
RFK Jr. Said ‘Everybody Can Get’ a Covid Vaccine. Is That True?
Although the FDA has approved the vaccines for anyone 65 or older and anyone at least 6 months old who is at risk of a severe covid infection, barriers to coverage and access persist.
What the Health? From KFF Health News: On Capitol Hill, RFK Defends Firings at CDC
A combative Robert F. Kennedy Jr, the U.S. secretary of health and human services, appeared before a Senate committee Thursday, defending his firing of the newly confirmed director of the Centers for Disease Control and Prevention as well as other changes that could limit the availability of vaccines. Meanwhile, Congress has only a few weeks to complete work on annual spending bills to avoid a possible government shutdown and to ward off potentially large increases in premiums for Affordable Care Act health plans. Jessie Hellmann of CQ Roll Call, Sarah Karlin-Smith of Pink Sheet, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Tony Leys, who discusses his “Bill of the Month” report about a woman’s unfortunate interaction with a bat — and her even more unfortunate interaction with the bill for her rabies prevention treatment.
FTC Has Long Said Products Must Back Up Health Claims. A MAHA Lawsuit Would Upend That.
Xlear, a maker of xylitol gum, has sued the Federal Trade Commission, saying the onus should be on government to prove that ingredients don’t live up to advertised claims. RFK Jr.’s “medical freedom” allies have rallied to the cause.
What the Health? From KFF Health News: Trump Further Politicizes Science
President Donald Trump’s latest executive order about science and medicine seeks to take funding decisions out of the hands of career scientists and give them to political appointees instead. And a gunman, reportedly disgruntled over covid vaccines, shoots at the headquarters of the Centers for Disease Control and Prevention, killing a law enforcement officer. Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Aaron Carroll, president and CEO of the health services research group AcademyHealth, about how to restore the public’s trust in public health.
Listen: Regulatory Rollbacks and Federal Layoffs Threaten America’s Food Supply
The Trump administration’s anti-regulatory approach and cost-cutting moves risk unraveling the system of checks and balances that helps ensure the safety of the U.S. food supply, say consumer advocates and former employees of the FDA and Department of Agriculture.
